MSA Data-Driven Solutions Help Pharma Resolve Minority Recruitment Issues

Differences in lived experiences, opportunity, and exposure to environmental stressors and toxins among racial/ethnic groups can be missed when clinical trials fail to test interventions on diverse participants. This lack of/or low representation of racial/ethnic minority groups in clinical trials could result in the development of interventions that do not translate well into real-world use and are not efficacious in different populations.

MSA Healthcare Data Management’s (HCDM) solutions help the industry focus the trial recruitment criteria on the disease prevalence from the get-go.  MSA HCDM’s leading technologies enable the gathering of trial recruitment data effort – including identifying the right places to pursue trial sites – increasing pharma’s access to minority patient and physician clusters. Through the use of real-world evidence, MSA helps pharma pinpoint high incidence rates and develop strategies for targeting/educating the most appropriate physicians and patients.

By enriching and integrating disease prevalence data with other data sources, such as MSA-provided Lab Diagnostic data, Medical Claims data, Hospital Charge data, and EHR Clinical data, MSA HCDM solutions optimize clinical trials via more efficient site and patient identification.

Download the Whitepaper Now